Human ‘challenge trials’ entail risk but they could be our best protection against the next pandemic
28th May 2024
Next-generation vaccines in development today could help prevent an outbreak from becoming the next global crisis.
28th May 2024
Next-generation vaccines in development today could help prevent an outbreak from becoming the next global crisis.
24th April 2024
On 17-18 April, the MusiCC consortium convened at Imperial College London to kick off its ambitious 5-year project.
14th March 2024
A £44m project aims to develop next-generation treatments that reduce disease severity and block transmission.
11th March 2024
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
11th March 2024
An international consortium of researchers specialising in human challenge studies is embarking on a US$57 million project to develop advanced, virus-blocking coronavirus vaccines.